Stock Analysts’ updated eps estimates for Monday, August 21st:
Adtalem Global Education (NASDAQ:ATGE) had its market perform rating reiterated by analysts at BMO Capital Markets. BMO Capital Markets currently has a $35.00 price target on the stock, down from their previous price target of $40.00.
Physicians Realty Trust (NYSE:DOC) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $21.00 target price on the stock, down from their previous target price of $23.00.
Horizon Technology Finance Corporation (NASDAQ:HRZN) was upgraded by analysts at Compass Point from a sell rating to a neutral rating.
Johnson Controls International PLC (NYSE:JCI) had its outperform rating reissued by analysts at Cowen and Company. They currently have a $48.00 price target on the stock.
LINDT & SPRUENGLI CHF10 (PTG CERT) (OTC:LDSVF) was upgraded by analysts at UBS AG from a neutral rating to a buy rating.
Monmouth Real Estate Investment Corporation (NYSE:MNR) had its buy rating reissued by analysts at National Securities. They currently have a $18.00 target price on the stock, up from their previous target price of $16.50. The analysts wrote, “Call to Action: With its recent quarter FFO dividend payout ratio of 90.1% the lowest in years, e-commerce retail sales growth driving demand for industrial space across the country, and a rock solid tenant roster, MNR is on the cusp of another dividend raise, a strong catalyst for the stock. Further, with only 8.9% of its near 100% leased 17,917,302 rentable square feet expiring through 9/30/18, MNR has the most attractive expiration schedule relative to its similarly sized market cap peers; TRNO has some 13.9% expiring and REXR, a troublesome 24.8% expiring. Its favorable expiration schedule will shield it from losing valuable tenants as is likely for others with a large amount of leases expiring, especially those with a large number of mixed-use tenants. Attributable to its near volatility free revenue stream, MNR continued to outperform on all metrics in the quarter and FYTD, again posting record single quarter revenue of $24.4mln, +17.4% Y/Y, record rent per square foot at $5.91, +4.4% Y/Y and record NOI of $24.04mln, +17.3% Y/Y. With a portfolio and tenant roster as enviable as MNR’s we feel its recent outperformance is likely to continue well into the future. As such, we’re maintaining our BUY rating and raising our $16.50 price target to $18.00.”
Perrigo (NYSE:PRGO) had its buy rating reissued by analysts at Cantor Fitzgerald.
Shake Shack (NYSE:SHAK) had its buy rating reissued by analysts at SunTrust Banks, Inc..
Shire PLC (NASDAQ:SHPG) had its buy rating reaffirmed by analysts at Cantor Fitzgerald.
Ulta Beauty (NASDAQ:ULTA) was given a $330.00 price target by analysts at Piper Jaffray Companies. The firm currently has a buy rating on the stock.
Valeant Pharmaceuticals International (NYSE:VRX) (TSE:VRX) was given a $19.00 target price by analysts at Deutsche Bank AG. The firm currently has a hold rating on the stock.
